Mizuho Markets Americas’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Sell
137,762
-19,600
-12% -$342K 0.03% 158
2026
Q1
$3.02M Buy
157,362
+12,745
+9% +$277K 0.08% 111
2025
Q4
$3.18M Buy
144,617
+27,255
+23% +$492K 0.06% 121
2025
Q3
$1.42M Sell
117,362
-21,380
-15% -$289K 0.03% 107
2025
Q2
$2.59M Buy
138,742
+22,970
+20% +$455K 0.08% 71
2025
Q1
$2.22M Buy
115,772
+30,680
+36% +$898K 0.05% 110
2024
Q4
$3.07M Buy
85,092
+14,024
+20% +$474K 0.05% 132
2024
Q3
$3.01M Sell
71,068
-1,188
-2% -$50.4K 0.06% 143
2024
Q2
$2.91M Buy
+72,256
New +$3.01M 0.07% 154

Other funds holding TNDM

Mizuho Markets Americas's TNDM Position: Q2 2026 in Review

Mizuho Markets Americas reduced its Tandem Diabetes Care (TNDM) stake by 12% in Q2 2026, selling an estimated $342K and leaving 137,762 shares worth $2.08M. The position accounts for 0.03% of the portfolio, ranked #158.

Mizuho Markets Americas first reported a position in TNDM in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.18M in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Mizuho Markets Americas held 137,762 shares of Tandem Diabetes Care worth $2.08M as of Q2 2026.
  • Mizuho Markets Americas sold 19,600 Tandem Diabetes Care shares in Q2 2026, an estimated $342K.
  • Tandem Diabetes Care made up 0.03% of Mizuho Markets Americas's portfolio in Q2 2026, its #158 holding.
  • Mizuho Markets Americas first reported a position in Tandem Diabetes Care in Q2 2024 and has held it in 9 quarters since.
  • Mizuho Markets Americas's Tandem Diabetes Care position peaked at $3.18M in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Mizuho Markets Americas's 13F filing for Q2 2026, filed 24 Jul 2026.